RxDoctor Payments Data

Christopher Sobey, MD

Pain Medicine · Nashville, TNNPI 1720221831

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,038 of the $9,848 with a category attached, or 61.3%. Boston Scientific accounts for 71.1% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $6,647, more than ten times the $100 reported in 2019.

$9,848in general payments, 2019–2025

Across 24 payments — averaging $410.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$7K
  • Ultragenyx Pharmaceutical Inc.$2K
  • Medtronic$374
  • Saluda Medical Americas, Inc.$362
  • SPR Therapeutics, Inc$148
  • Comsort, Inc$100
  • plus $66 from 1 others
$125in research payments, 2019–2025

Across 1 payment — averaging $125.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Indivior Inc.$125

What the payments were for

  • Consulting fees$6,03861%
  • Speaking & faculty fees$1,80018%
  • Travel & lodging$6917%
  • Food & beverage$1,31913%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,848 in reported general payments places this provider in the 75th percentile of 112 pain medicine providers in Tennessee.

See all pain medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$203,107
Medicare patients
391
Services billed
7,990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine49$9,118
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl36$6,231
Duloxetine Hcl162$4,211
Gabapentin126$2,647
Celecoxib36$1,538
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen88$1,454
Pregabalin73$1,240
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen99$1,198
Naloxone Hcl15$1,046
Mupirocin72$576
Memantine Hcl15$482
Methocarbamol31$348
Tizanidine Hcl32$242
Cyclobenzaprine Hcl30$231
Tramadol Hcl65$202

Paid to pharmacies, not to this prescriber.

Other pain medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →